LOL, that just the fear mongering BS being thrown around from Collie Dog and Acne Faced Maquarie Junior analyst. This partnership is chump change for Novartis, the upside far outweighs the risks. Novartis want to move into regenerative cellular medicine in a big way. Traditional treatments will begin to phase themselves when revolutionary treatments emerge. MSB have the keys.
MSB Trading 2021 - paradigm shift, page-1829
-
- There are more pages in this discussion • 8,382 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.117M | 3.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 29960 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 12639 | 4 |
View Market Depth
| Last trade - 13.13pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |